← brief for 2026-10-22 · Slowing decline
Inibidores de SGLT2 e proteção renal: evidências científicas e impacto na progressão da doença renal crônica.
Key takeaways
This review summarizes evidence that SGLT2 inhibitors slow kidney decline. It covers studies in people with and without diabetes. It does not report new trial results.
Who did this work
Fernando Vieira de Paiva Borges · Roberto Araújo de Oliveira Filho · Levi Anderson Silva Sousa · Leandro Silva da Conceição · Nícolas Oliveira de Araújo
Source
Article · OpenAlex, CKD works · 2026-10-21
https://doi.org/10.69849/mq37w703